Gliadel® Wafer is carmustine implant that is indicated for patients with newly diagnosed high-grade malignant glioma as an adjunct to surgery and radiation. Gliadel® Wafer is also indicated in patients with recurrent glioblastoma multiforme as an adjunct to surgery. The implant It is placed on the area in the brain during operation. Since the implant is biodegradable, there is no need to remove it in a repeat surgical procedure.
Facebook
Twitter
LinkedIn
WhatsApp
Gliadel®
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
Advanced Breast Cancer
Advanced Cancer Treatment
ASCO 2025
ASCO 2026
Biological Drugs
Breast Oncology
Cancer Research
CAR T treatments
centralny układ nerwowy
Chemotherapy
Clinical Trial Enrollment
Clinical Trials
Fulvestrant
Gedatolisib
Genetic Engineering Treatments
Genomic Testing
HER3-DXd
Hormone Receptor Positive Breast Cancer
Immunotherapy
innowacyjne terapie onkologiczne
Keytruda
KRAS
leczenie LMD
leki biologiczne
Medical Cannabis
Metastatic Pancreatic Cancer
Novel Cancer Therapies
nowe leczenie raka
Oncology
OrigAMI-4
Pancreatic Cancer
Precision Oncology
przerzuty do opon mózgowo-rdzeniowych
Recurrent Head and Neck Cancer
Revolution Medicines
Rybrevant
Rybrevant FASPRO
Stage 4 Cancer
Stage IV Breast Cancer
Tango Therapeutics
Targeted Drugs
Targeted Therapy
Trial-In Pharma
VIKTORIA-1
Vopimetostat
